Marwa Mohsen: Proud to Contribute to WHO’s Blood Safety Harmonization Efforts
Marwa Mohsen, Deputy Director General at National Blood Transfusion Services, shared on LinkedIn:
”I’m proud to share that my WHO Working Group on Harmonizing Terminology in Blood Safety presented our progress at the 39th International ISBT Congress held in Kuala Lumpur – Malaysia .
As part of the WHO Advisory Group on Blood Regulation, Availability and Safety [AG BRAS], our working party that was established in 2022 addressed a critical gap: inconsistent definitions undermine the comparability of global blood safety data.
Definitely Clear, harmonized terminology is essential for reliable monitoring, data exchange, and interoperability as health systems become increasingly digital. Without harmonization of terminologies ,we can’t compare data, learn from each other, or respond quickly in emergencies.
It was an honor to contribute to this global effort to improve the consistency and safety of blood products worldwide.
Honored to be part of this WHO advisory group representing Egypt and upper Africa since 2021 and to work with experts from around the world on this.
Grateful to my co-authors, AG BRAS, WHO, and ISBT for the collaboration.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI